Stock listing
Maxigen Biotech Inc.
Selected listing: 1783 · TWSE · TWD · TW
Maxigen Biotech Inc. (TWSE:1783), Health Technology. Latest release Aug 9, 2022: Maxigen Biotech : Monthly revenue report, July 2022.
- Ticker
- TWSE:1783
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- TWSE
- Currency
- TWD
About Maxigen Biotech Inc.
Maxigen Biotech Inc. is a public company traded on the Taiwan market under the ticker 1783. Maxigen focuses on biotechnological innovations and advancements in the healthcare sector.
Latest news from Maxigen Biotech Inc.
Maxigen Biotech : Monthly revenue report, July 2022
August 9, 2022
Maxigen Biotech : Board of Directors approved the financial reports for the second quarter of 2022
August 3, 2022
Maxigen Biotech : Monthly revenue report, June 2022
July 7, 2022
Maxigen Biotech : The Company's 2022 Annual Shareholder's Meeting approved the removal of the Company's new directors and their representatives from non-competition restrictions
June 21, 2022
Maxigen Biotech : Announcement of the election of two additional directors at the Company's 2022 Annual General Meeting
June 21, 2022
Research Maxigen Biotech Inc.
Maxigen Biotech Inc. company profile
View the public company page for Maxigen Biotech Inc. on 6ix.
Maxigen Biotech Inc. news
Read company news and market updates connected to Maxigen Biotech Inc..
Maxigen Biotech Inc. investor events
Find investor webinars, events, and replay context for Maxigen Biotech Inc..